Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

RESP Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first U.S.-based patients in dapsone trial has started

Research on dysanapsis recognized by McGill Medstar Award for Trainees

Congratulations to RI-MUHC trainee Motahareh Vameghestahbanati!

Can inhaled corticosteroids alleviate early symptoms of COVID-19?

Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo

Regular screening for tuberculosis in Inuit communities is cost-effective

A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

The 2021 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

RI-MUHC researchers contribute to global study of babies born with birth defects

A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...

RI-MUHC success in grant competition for transplantation research

Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...

Explore news and events at the RI-MUHC